These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27659555)

  • 21. Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control.
    Szechtman H; Eckert MJ; Tse WS; Boersma JT; Bonura CA; McClelland JZ; Culver KE; Eilam D
    BMC Neurosci; 2001; 2():4. PubMed ID: 11316464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Perreault ML; Szechtman H
    Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
    Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA
    Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
    Shanahan NA; Velez LP; Masten VL; Dulawa SC
    Biol Psychiatry; 2011 Dec; 70(11):1039-48. PubMed ID: 21920503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.
    Ramasubbu R; Ravindran A; Lapierre Y
    Pharmacopsychiatry; 2000 Nov; 33(6):236-8. PubMed ID: 11147933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole.
    Jung TD; Jung PS; Raveendran L; Farbod Y; Dvorkin-Gheva A; Sakic B; Surette MG; Szechtman H
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):211-224. PubMed ID: 29194070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J
    Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Adenosine A
    Asaoka N; Nishitani N; Kinoshita H; Nagai Y; Hatakama H; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
    eNeuro; 2019; 6(1):. PubMed ID: 30834304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.
    Escobar AP; Cornejo FA; Olivares-Costa M; González M; Fuentealba JA; Gysling K; España RA; Andrés ME
    J Neurochem; 2015 Sep; 134(6):1081-90. PubMed ID: 26112331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age differences in an animal model of obsessive-compulsive disorder: participation of dopamine: dopamine in an animal model of OCD.
    Ulloa RE; Nicolini H; Fernández-Guasti A
    Pharmacol Biochem Behav; 2004 Aug; 78(4):661-6. PubMed ID: 15301919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of cost manipulation on water contrafreeloading induced by repeated exposure to quinpirole in the rat.
    Milella MS; Amato D; Badiani A; Nencini P
    Psychopharmacology (Berl); 2008 Apr; 197(3):379-90. PubMed ID: 18189126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms.
    Perreault ML; Graham D; Bisnaire L; Simms J; Hayton S; Szechtman H
    Neuropsychopharmacology; 2006 Sep; 31(9):1967-81. PubMed ID: 16237381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Culver KE; Waxman D; Szechtman H; Kolb B
    Behav Pharmacol; 2008 Jul; 19(4):271-83. PubMed ID: 18622174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
    Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
    Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Issues in the pharmacological treatment of obsessive-compulsive disorder.
    Math SB; Janardhan Reddy YC
    Int J Clin Pract; 2007 Jul; 61(7):1188-97. PubMed ID: 17511795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder.
    Korff S; Stein DJ; Harvey BH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):348-55. PubMed ID: 17888556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report.
    Paholpak S
    J Med Assoc Thai; 2002 Oct; 85(10):1135-8. PubMed ID: 12501907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.